Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
O’Callaghan, 2010, The role of inflammation in the pathogenesis of non-small cell lung cancer, J Thorac Oncol, 5, 2024, 10.1097/JTO.0b013e3181f387e4
Aggarwal, 2009, Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe, Clin Cancer Res, 15, 425, 10.1158/1078-0432.CCR-08-0149
Roxburgh, 2010, Role of systemic inflammatory response in predicting survival in patients with primary operable cancer, Future Oncol, 6, 149, 10.2217/fon.09.136
Vigano, 2000, Clinical survival predictors in patients with advanced cancer, Arch Intern Med, 160, 861, 10.1001/archinte.160.6.861
McMillan, 2013, The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer, Cancer Treat Rev, 39, 534, 10.1016/j.ctrv.2012.08.003
Guthrie, 2013, The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer, Crit Rev Oncol Hematol, 88, 218, 10.1016/j.critrevonc.2013.03.010
Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, e1000100, 10.1371/journal.pmed.1000100
Deeks, Chapter 9: Analysing data and undertaking meta-analyses
Pinato, 2012, Inflammation-based prognostic indices in malignant pleural mesothelioma, J Thorac Oncol, 7, 587, 10.1097/JTO.0b013e31823f45c1
Petrie, 1985, Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes, J Immunol, 134, 230, 10.4049/jimmunol.134.1.230
el-Hag, 1987, Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system, J Immunol, 139, 2406, 10.4049/jimmunol.139.7.2406
Loi, 2013, Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98, J Clin Oncol, 31, 860, 10.1200/JCO.2011.41.0902
Gooden, 2011, The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis, Br J Cancer, 105, 93, 10.1038/bjc.2011.189
Denkert, 2010, Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer, J Clin Oncol, 28, 105, 10.1200/JCO.2009.23.7370
Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0
Motomura, 2013, Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment, J Hepatol, 58, 58, 10.1016/j.jhep.2012.08.017
Kantola, 2012, Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma, Br J Cancer, 107, 1729, 10.1038/bjc.2012.456
McCourt, 1999, Proinflammatory mediators stimulate neutrophil-directed angiogenesis, Arch Surg, 134, 1325, 10.1001/archsurg.134.12.1325
Di Carlo, 2003, Neutrophils in the antitumoral immune response, Chem Immunol Allergy, 83, 182, 10.1159/000071561
McCourt, 2001, Activated human neutrophils release hepatocyte growth factor/scatter factor, Eur J Surg Oncol, 27, 396, 10.1053/ejso.2001.1133
Jablonska, 2001, TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients, Arch Immunol Ther Exp (Warsz), 49, 63
Schaider, 2003, Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8, Int J Cancer, 103, 335, 10.1002/ijc.10775
Shamamian, 2001, Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis, J Cell Physiol, 189, 197, 10.1002/jcp.10014
Scapini, 2002, Generation of biologically active angiostatin kringle 1–3 by activated human neutrophils, J Immunol, 168, 5798, 10.4049/jimmunol.168.11.5798
Ohsugi, 2007, Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases, Biol Pharm Bull, 30, 2001, 10.1248/bpb.30.2001
Lippitz, 2013, Cytokine patterns in patients with cancer: a systematic review, Lancet Oncol, 14, e218, 10.1016/S1470-2045(12)70582-X
Templeton, 2013, New prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil to lymphocyte ratio, European Cancer Congress
Kao, 2010, High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy, Clin Cancer Res, 16, 5805, 10.1158/1078-0432.CCR-10-2245
Chua, 2011, Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer, Br J Cancer, 104, 1288, 10.1038/bjc.2011.100
Botta, 2011, Treatment-related changes in systemic inflammatory status, measured by neutrophil-to-lymphocyte ratio, is predictive of outcome in metastatic colorectal cancer patients, Eur J Cancer, 47, S181, 10.1016/S0959-8049(11)70932-7
Lee, 2012, Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy, J Cancer Res Clin Oncol, 138, 2009, 10.1007/s00432-012-1281-4
Leibowitz-Amit, 2013, Novel predictive markers of PSA response to abiraterone acetate in men with metastatic castration-resistant-prostate-cancer (mCRPC), J Clin Oncol, 31, 10.1200/jco.2013.31.15_suppl.5058
Park, 2013, Neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first-line therapy, J Urol, 189(4), e787, 10.1016/j.juro.2013.02.2338
Azab, 2011, Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis, Pancreatology, 11, 445, 10.1159/000331494
Park, 2013, Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention, Am J Cardiol, 111, 636, 10.1016/j.amjcard.2012.11.012
An, 2010, Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer, Biomarkers, 15, 516, 10.3109/1354750X.2010.491557
Cima, 2011, Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer, Proc Natl Acad Sci U S A, 108, 3342, 10.1073/pnas.1013699108
Azab, 2013, Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients, Med Oncol, 30, 432, 10.1007/s12032-012-0432-4
Bhatti, 2010, Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio, Am J Surg, 200, 197, 10.1016/j.amjsurg.2009.08.041
Carruthers, 2012, Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer, Colorectal Dis, 14, e701, 10.1111/j.1463-1318.2012.03147.x
Cedres, 2012, Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer, Clin Transl Oncol, 14, 864, 10.1007/s12094-012-0872-5
Cetin, 2013, Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?, Clin Genitourinary Cancer, 11, 141, 10.1016/j.clgc.2012.09.001
Chen, 2012, Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation, J Gastroenterol Hepatol, 27, 553, 10.1111/j.1440-1746.2011.06910.x
Chiang, 2012, Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?, Int J Colorectal Dis, 27, 1347, 10.1007/s00384-012-1459-x
Cho, 2009, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunology, Immunotherapy, 58, 15, 10.1007/s00262-008-0516-3
Chua, 2011, Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer, Br J Cancer, 104, 1288, 10.1038/bjc.2011.100
Chua, 2012, Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer, Supportive Care Cancer, 20, 1869, 10.1007/s00520-011-1289-3
Ding, 2010, Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer, Int J Colorectal Dis, 25, 1427, 10.1007/s00384-010-1052-0
Dutta, 2011, Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer, World J Surg, 35, 1861, 10.1007/s00268-011-1130-7
Dutta, 2012, Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer, Am J Surg, 204, 294, 10.1016/j.amjsurg.2011.10.015
Gomez, 2008, Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma, J Surg Oncol, 97, 513, 10.1002/jso.21001
Gomez, 2008, Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis, J Surg Oncol, 98, 371, 10.1002/jso.21103
Gomez, 2008, Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma, World J Surg, 32, 1757, 10.1007/s00268-008-9552-6
Gondo, 2012, Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy, Urology, 79, 1085, 10.1016/j.urology.2011.11.070
Guo, 2009, Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma, Chinese J Cancer, 28, 75, 10.5732/cjc.009.10073
Halazun, 2008, Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases, Eur J Surg Oncol, 34, 55, 10.1016/j.ejso.2007.02.014
Halazun, 2009, Negative impact of neutrophil-lymphocyte ratio on outcome following liver transplantation for hepatocellular carcinoma (HCC), Am J Transplant, 9, 286
He, 2012, Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma, Head Neck, 34, 1769, 10.1002/hed.22008
Huang, 2011, Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization, J Vasc Interv Radiol, 22, 702, 10.1016/j.jvir.2010.12.041
Hung, 2011, Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy, Int J Colorectal Dis, 26, 1059, 10.1007/s00384-011-1192-x
Idowu, 2012, Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma, Biomarkers, 17, 539, 10.3109/1354750X.2012.699554
Jeong, 2012, Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer, Oncology (Switzerland), 83, 292
Jung, 2011, Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer, J Surg Oncol, 104, 504, 10.1002/jso.21986
Kaneko, 2012, Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy, Oncology (Switzerland), 82, 261
Kao, 2010, High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy, Clin Cancer Res, 16, 5805, 10.1158/1078-0432.CCR-10-2245
Kao, 2011, Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy, J Thorac Oncol, 6, 1923, 10.1097/JTO.0b013e31822a3740
Kao, 2013, Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board, Clin Lung Cancer, 14, 70, 10.1016/j.cllc.2012.03.011
Keizman, 2012, Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram, Oncologist, 17, 1508, 10.1634/theoncologist.2012-0125
Kim, 2012, The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery, J Korean Surg Soc, 83, 352, 10.4174/jkss.2012.83.6.352
Kishi, 2009, Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy, Ann Surg Oncol, 16, 614, 10.1245/s10434-008-0267-6
Koh, 2012, Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma, AM J Clin Pathol, 138, 846, 10.1309/AJCPO46GFKGNXCBR
Kunisaki, 2012, Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy, Oncology (Switzerland), 83, 183
Kwon, 2012, Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer, Biomarkers, 17, 216, 10.3109/1354750X.2012.656705
Lee, 2012, Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma, Anticancer Res, 32, 1555
Leitch, 2007, Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer, Br J Cancer, 97, 1266, 10.1038/sj.bjc.6604027
Limaye, 2011, Evaluation of the neutrophil-lymphocyte ratio as a predictor of survival after liver transplantation for hepatocellular carcinoma, J Clin Oncol, 29, 10.1200/jco.2011.29.4_suppl.170
Liu, 2010, The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma, J Gastrointest Cancer, 41, 116, 10.1007/s12029-009-9125-4
Malik, 2007, Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases, Ann Surg, 246, 806, 10.1097/SLA.0b013e318142d964
Mallappa, 2013, Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer, Colorectal Dis, 15, 323, 10.1111/codi.12008
Miyata, 2011, Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer, Exp Ther Med, 2, 879, 10.3892/etm.2011.308
Mohri, 2010, Prognostic significance of host- and tumor-related factors in patients with gastric cancer, World J Surg, 34, 285, 10.1007/s00268-009-0302-1
Motomura, 2013, Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment, J Hepatol, 58, 58, 10.1016/j.jhep.2012.08.017
Neal, 2009, Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases, Eur J Cancer, 45, 56, 10.1016/j.ejca.2008.08.019
Ohno, 2010, Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma, J Urol, 184, 873, 10.1016/j.juro.2010.05.028
Ohno, 2012, Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma, J Urol, 187, 411, 10.1016/j.juro.2011.10.026
Ohno, 2014, Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status, Int J Clin Oncol, 19, 139, 10.1007/s10147-012-0514-5
Perez, 2013, Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor, Ann Surg Oncol, 20, 593, 10.1245/s10434-012-2682-y
Perisanidis, 2013, High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer, Med Oncol, 30, 334, 10.1007/s12032-012-0334-5
Pinato, 2012, Inflammation-based prognostic indices in malignant pleural mesothelioma, J Thorac Oncol, 7, 587, 10.1097/JTO.0b013e31823f45c1
Pinato, 2012, A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI), J Hepatol, 57, 1013, 10.1016/j.jhep.2012.06.022
Proctor, 2012, A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer, Br J Cancer, 107, 695, 10.1038/bjc.2012.292
Sarraf, 2009, Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer, J Thorac Cardiovasc Surg, 137, 425, 10.1016/j.jtcvs.2008.05.046
Sharaiha, 2011, Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer, Ann Surg Oncol, 18, 3362, 10.1245/s10434-011-1754-8
Shimada, 2010, High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer, Gastric Cancer, 13, 170, 10.1007/s10120-010-0554-3
Shouyu, 2011, The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis, Oncol Lett, 2, 735, 10.3892/ol.2011.304
Smith, 2009, Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma, Am J Surg, 197, 466, 10.1016/j.amjsurg.2007.12.057
Sonpavde, 2012, Prognostic stratification of post-docetaxel metastatic castration resistant prostate cancer (mCRPC) from a phase III randomized trial, J Clin Oncol, 30, 10.1200/jco.2012.30.15_suppl.4644
Teramukai, 2009, Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03, Eur J Cancer, 45, 1950, 10.1016/j.ejca.2009.01.023
Tomita, 2012, Elevated preoperative inflammatory markers based on,neutrophil-to- lymphocyteratio and C-reactive protein predict poor survival in resected non-small cell lung cancer, Anticancer Res, 32, 3535
Ubukata, 2010, Characteristics of the serum pepsinogen (Pg) test, and the relationship between Pg test results and gastric cancer outcomes, Scand J Surg, 99, 201, 10.1177/145749691009900404
Wang, 2011, A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation, PLoS One, 6, 10.1371/journal.pone.0025295
Wang, 2012, Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer, Med Oncol, 29, 3092, 10.1007/s12032-012-0226-8
Wang, 2012, Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer, Tumour Biol, 33, 749, 10.1007/s13277-011-0285-z
Yamanaka, 2007, The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer, Oncology, 73, 215, 10.1159/000127412
Yao, 2013, Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy, Cancer Immunol Immunother, 62, 471, 10.1007/s00262-012-1347-9
Zhang, 2012, Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation, Int J Hyperthermia, 28, 132, 10.3109/02656736.2011.654374
Dumitrascu, 2013, Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome, J Gastrointest Surg, 17, 913, 10.1007/s11605-013-2144-2
Jafri, 2013, Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review, BMC Cancer, 13
Kobayashi, 2013, Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy, Med Oncol, 30, 556, 10.1007/s12032-013-0556-1
Noh, 2013, Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients, J Breast Cancer, 16, 55, 10.4048/jbc.2013.16.1.55
Oh, 2013, Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma, BMC Cancer, 13
Pichler, 2013, Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients, Br J Cancer, 108, 901, 10.1038/bjc.2013.28
Szkandera, 2013, Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients, Br J Cancer, 108, 1677, 10.1038/bjc.2013.135
Azab, 2012, Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients, Ann Surg Oncol, 19, 217, 10.1245/s10434-011-1814-0
Asher, 2011, Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer, Clin Transl Oncol, 13, 499, 10.1007/s12094-011-0687-9
Bambury, 2012, The association of pretreatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme (GBM), J Clin Oncol, 30, abstract 2062, 10.1200/jco.2012.30.15_suppl.2062
Berger, 2012, Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease (mRCC) treated with sunitinib (Su), J Clin Oncol, 30, abstract e15058, 10.1200/jco.2012.30.15_suppl.e15058
Botta, 2011, Baseline inflammatory status defined by neutrophil to lymphocyte cell count ratio (NLR) predicts progression free survival (PFS) in metastatic colorectal cancer patients (mCRC) undergoing bevacizumab based biochemotherapy, Eur J Cancer, 47 (Suppl), S174, 10.1016/S0959-8049(11)70911-X
Chen, 2012, Correlation of specific cytokine profiles with high blood neutrophil-to-lymphocyte ratio and outcome in metastatic colorectal cancer, J Clin Oncol, 30, abstract 3598, 10.1200/jco.2012.30.15_suppl.3598
Harji, Neutrophil-lymphocyte ratio as a predictor of survival in locally recurrent rectal cancer
Huang, 2011, The association of pretreatment (pre-tx) neutrophil to lymphocyte ratio (NLR) with outcome of sunitinib tx in patients (pts) with metastatic renal cell carcinoma (mRCC), J Clin Oncol, 10.1200/jco.2011.29.15_suppl.4621
Kim, Predictors of survival in patients with refractory metastatic colorectal cancer, J Clin Oncol, 2011
Krane, 2013, Preoperative neutrophil lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy, J Endourol, 27, 1046, 10.1089/end.2012.0606
Lee, 2012, The clinical significance of neutrophil-lymphocyte ratio versus platelet-lymphocyte ratio in patients with metastatic gastric cancer, J Clin Oncol, 30, abstract e14686, 10.1200/jco.2012.30.4_suppl.660
Mohamed, 2012, Novel inflammation-based prognostic determinants in patients with carcinoma of unknown primary, abstract 1169P
Sella, 2012, Pretreatment (pre-tx) neutrophil to lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with ketoconazole (keto): Association with outcome and predictive model, J Clin Oncol, 30, abstract 4564, 10.1200/jco.2012.30.15_suppl.4564
Toh, 2014, Neutrophil-lymphocyte ratio (NLR) as a simple and novel biomaker in predicting locoregional recurrence after chemoradiotherapy for squamous cell carcinoma (SCC) of the anus, Colorectal Dis, 16, O90, 10.1111/codi.12467
Cedres Perez, 2011, PI3K pathway and downstream signaling analysis in malignant pleural mesothelioma (MPM), J Clin Oncol, 10.1200/jco.2011.29.15_suppl.7057
De Vincenzo, 2011, NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM), J Clin Oncol, 29, abstract 7089, 10.1200/jco.2011.29.15_suppl.7089
McNamara, 2013, Neutrophil/lymphocyte ratio (NLR) as a prognostic factor in biliary tract cancer (BTC), J Clin Oncol, 31, abstract 4130, 10.1200/jco.2013.31.15_suppl.4130
Pass, 2013, Plasma osteopontin and the prognosis of pleural mesothelioma, J Clin Oncol, 31, abstract 11109, 10.1200/jco.2013.31.15_suppl.11109
Tran, 2012, Can systemic inflammation at diagnosis predict benefit from primary resection in metastatic colorectal cancer (mCRC)?, J Clin Oncol, 30, abstract 410